Skip to main content
. 2020 Sep 17;21(18):6823. doi: 10.3390/ijms21186823

Figure 5.

Figure 5

Experimental design graph; CL (corpus luteum), BCL2 (B-cell lymphoma), BAX (bcl-2-like protein 4), PCNA (proliferating cells nuclear antigen), VEGFA (vascular endothelial growth factor), FGF2 (fibroblast growth factor 2), ANGPT1 (angiopoietin 1), GRP78 (78-kDa glucose-regulated protein) MAP3/1 (mitogen activated kinase), and VEGFR1/2 (endothelial growth factor receptors), * scoring/pause.